University of Massachusetts Medical School Faculty Publications
Title
Intracranial hemorrhage with target specific oral anticoagulants in patients with atrial fibrillation: An updated meta-analysis of randomized controlled trials
UMMS Affiliation
Department of Medicine, Division of Cardiovascular Medicine
Publication Date
1-15-2016
Document Type
Article
Disciplines
Cardiology | Cardiovascular Diseases
Abstract
Although individual trials with Target Specific Oral Anticoagulants (TSOACs) have shown decreased rates of intracranial hemorrhage (ICH), there is limited data regarding the absolute and relative benefit of TSOACs in prevention of ICH. We performed a meta analysis to evaluate the absolute risk of ICH with TSOACs in patients with atrial fibrillation (AF), using data from the most recent clinical trials.
Keywords
Apixaban, Atrial fibrillation, Dabigatran, Edoxaban, Intracranial hemorrhage, Rivaroxaban
DOI of Published Version
10.1016/j.ijcard.2015.11.097
Source
Int J Cardiol. 2016 Jan 15;203:1000-2. doi: 10.1016/j.ijcard.2015.11.097. Epub 2015 Nov 17. Link to article on publisher's site
Related Resources
Journal/Book/Conference Title
International journal of cardiology
PubMed ID
26630621
Repository Citation
Kundu, Amartya; Sen, Parijat; Sardar, Partha; Chatterjee, Saurav; Kapoor, Alok; and McManus, David D., "Intracranial hemorrhage with target specific oral anticoagulants in patients with atrial fibrillation: An updated meta-analysis of randomized controlled trials" (2016). University of Massachusetts Medical School Faculty Publications. 858.
https://escholarship.umassmed.edu/faculty_pubs/858